These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16982876)

  • 1. Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions.
    Durakovic N; Bezak KB; Skarica M; Radojcic V; Fuchs EJ; Murphy GF; Luznik L
    J Immunol; 2006 Oct; 177(7):4414-25. PubMed ID: 16982876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.
    Durakovic N; Radojcic V; Skarica M; Bezak KB; Powell JD; Fuchs EJ; Luznik L
    Blood; 2007 May; 109(10):4564-74. PubMed ID: 17227829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.
    De Somer L; Sprangers B; Fevery S; Rutgeerts O; Lenaerts C; Boon L; Waer M; Billiau AD
    Haematologica; 2011 Mar; 96(3):424-31. PubMed ID: 21109687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants.
    Billiau AD; Fevery S; Rutgeerts O; Landuyt W; Waer M
    Blood; 2002 Sep; 100(5):1894-902. PubMed ID: 12176914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.
    Ash S; Stein J; Askenasy N; Yaniv I
    Br J Cancer; 2010 Nov; 103(10):1597-605. PubMed ID: 20978501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.
    Merad M; Hoffmann P; Ranheim E; Slaymaker S; Manz MG; Lira SA; Charo I; Cook DN; Weissman IL; Strober S; Engleman EG
    Nat Med; 2004 May; 10(5):510-7. PubMed ID: 15098028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction.
    Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
    Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
    J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice.
    Racine J; Wang M; Zhang C; Lin CL; Liu H; Todorov I; Atkinson M; Zeng D
    Diabetes; 2011 Feb; 60(2):555-64. PubMed ID: 21270266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation.
    Ratzinger G; Reagan JL; Heller G; Busam KJ; Young JW
    Blood; 2003 Feb; 101(4):1422-9. PubMed ID: 12393688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N; Radojcic V; Powell J; Luznik L
    Transplantation; 2007 Mar; 83(5):631-40. PubMed ID: 17353785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.